Anemia is a condition defined by insufficient red blood cells or hemoglobin in blood, reducing oxygen-carrying capacity and causing tissues and organs to receive inadequate oxygen. Red blood cells are produced in bone marrow and contain hemoglobin—an iron-containing protein that binds oxygen in lungs and releases it to tissues. When red blood cell production decreases, red blood cells are destroyed too quickly, or blood is lost, anemia develops.

Anemia is remarkably common, affecting approximately 1.62 billion people worldwide—nearly one-quarter of the global population. Women of childbearing age have highest rates due to menstrual blood loss and pregnancy demands. Elderly individuals have increased rates due to chronic diseases, nutritional deficiencies, and age-related bone marrow changes. In developing countries, anemia affects up to 50% of women and children due to inadequate nutrition, parasitic infections, and limited healthcare.

Symptoms result from reduced oxygen delivery to tissues. Fatigue and weakness are universal complaints, often the earliest symptoms. Other common manifestations include shortness of breath (particularly with exertion), dizziness, pale skin, cold hands and feet, headaches, and rapid heartbeat. Symptom severity correlates with anemia severity and how quickly it develops—sudden blood loss causes more dramatic symptoms than slow-onset anemia, which allows physiologic compensation.

Anemia is rarely a disease itself but rather a sign of underlying conditions requiring identification. Iron deficiency from inadequate dietary intake, menstrual blood loss, or gastrointestinal bleeding is the most common cause globally. Vitamin deficiencies (B12, folate) cause specific anemia types with neurological complications if untreated. Chronic diseases—kidney disease, cancer, autoimmune disorders—commonly cause anemia through multiple mechanisms. Genetic conditions like sickle cell disease and thalassemia cause lifelong anemia requiring specialized management. Identifying the anemia type and underlying cause is essential for appropriate treatment.

Diagnosis relies on blood testing. A complete blood count (CBC) confirms anemia and provides clues to cause. Additional tests—iron studies (ferritin, serum iron, TIBC), vitamin B12, folate, reticulocyte count—identify specific causes. Treatment targets the underlying cause: iron supplementation for iron deficiency, vitamin replacement for deficiency anemias, treating kidney disease or inflammatory conditions for anemia of chronic disease. With proper diagnosis and treatment, most anemias are correctable, dramatically improving energy, quality of life, and preventing complications.

Quick Summary:

• Anemia affects 1.62 billion people worldwide—approximately 25% of the global population
• Iron deficiency is the most common cause, affecting over 1 billion people, particularly women and children
• Classic symptoms include fatigue, weakness, shortness of breath, pale skin, dizziness, cold hands/feet, rapid heartbeat
• Hemoglobin defines anemia: <13 g/dL in men, <12 g/dL in non-pregnant women, <11 g/dL in pregnant women
• Multiple causes including iron deficiency, vitamin B12 deficiency, folate deficiency, chronic disease, blood loss, genetic conditions, bone marrow disorders
• Blood testing is essential: CBC shows hemoglobin and red blood cell characteristics; additional tests (ferritin, iron studies, B12, folate) identify cause
• Iron deficiency anemia has low hemoglobin, low ferritin (<30 ng/mL), low serum iron, high TIBC—treated with iron supplementation
• Vitamin B12 deficiency causes macrocytic anemia plus neurological symptoms—requires B12 injections or high-dose oral B12
• Anemia of chronic disease from kidney disease, cancer, inflammation—treated by addressing underlying condition
• Complications of untreated anemia include heart problems (heart failure in severe cases), cognitive impairment, pregnancy complications, impaired immune function
• Prevention strategies include adequate dietary iron, routine screening in high-risk groups (pregnant women, frequent blood donors, heavy periods), addressing underlying conditions
• Most anemias are treatable with appropriate diagnosis and intervention—iron supplementation, vitamin replacement, or treating underlying diseases

---

What Are Red Blood Cells and Hemoglobin?

Red Blood Cells (Erythrocytes)

Red blood cells are the most abundant cells in blood—approximately 25 trillion circulate in an average adult at any time, comprising 40-45% of blood volume. Red blood cells are uniquely structured for oxygen transport: biconcave disc shape (increasing surface area for gas exchange), lacking nucleus and mitochondria (maximizing space for hemoglobin), and flexible membrane (allowing passage through tiny capillaries).

Red blood cells are produced in bone marrow through erythropoiesis, a process requiring iron, vitamin B12, folate, and other nutrients. Production is stimulated by erythropoietin (EPO), a hormone produced primarily by kidneys in response to low oxygen levels. Normal red blood cell lifespan is approximately 120 days, after which they’re removed by spleen and liver, and their components (including iron) are recycled for new red blood cell production.

Hemoglobin

Hemoglobin is the iron-containing protein inside red blood cells responsible for oxygen transport. Each hemoglobin molecule contains four iron atoms, each capable of binding one oxygen molecule. Hemoglobin’s unique structure allows it to bind oxygen in high-oxygen environments (lungs) and release oxygen in low-oxygen environments (tissues).

Normal hemoglobin levels vary by age and sex:

• Adult men: 13.5-17.5 g/dL
• Adult women: 12.0-15.5 g/dL
• Pregnant women: 11.0-14.0 g/dL (lower due to blood volume expansion)
• Children: Varies by age, generally 11.0-16.0 g/dL

Anemia is defined as hemoglobin below these reference ranges. Severity is categorized as:

• Mild anemia: Hemoglobin 10-12 g/dL (women) or 10-13 g/dL (men)
• Moderate anemia: Hemoglobin 8-10 g/dL
• Severe anemia: Hemoglobin <8 g/dL
• Life-threatening anemia: Hemoglobin <6.5 g/dL

Oxygen Delivery

The primary function of red blood cells is oxygen delivery. Hemoglobin binds oxygen in lungs (where oxygen concentration is high), travels through bloodstream to tissues, and releases oxygen where it’s needed (where oxygen concentration is low). Carbon dioxide, a metabolic waste product, is transported back to lungs for exhalation.

When anemia reduces hemoglobin or red blood cell count, oxygen delivery to tissues decreases, forcing the body to compensate. Initial compensations include increased heart rate (pumping blood faster), increased cardiac output (pumping more blood per beat), and increased oxygen extraction from blood. These compensations explain why anemia symptoms often manifest during exertion (when oxygen demands exceed compensatory capacity) and why rapid heart rate and shortness of breath are common.

---

Symptoms of Anemia

Anemia symptoms reflect inadequate oxygen delivery to tissues. Symptom severity depends on anemia severity, how rapidly it developed, and individual compensation abilities. Gradual-onset anemia allows physiologic adaptations, causing fewer symptoms than sudden blood loss producing equivalent hemoglobin levels.

Common Symptoms

Fatigue and Weakness:

The most common and often earliest symptom, present in nearly all people with anemia. Persistent tiredness despite adequate sleep, reduced energy for daily activities, feeling physically drained. Fatigue worsens with exertion and improves with rest. This nonspecific symptom is easily dismissed as stress, poor sleep, or aging.

Shortness of Breath:

Difficulty breathing, particularly with physical exertion. Activities that previously caused no breathlessness—climbing stairs, walking uphill, exercise—now cause significant dyspnea. In severe anemia, shortness of breath occurs even at rest.

Dizziness and Lightheadedness:

Feeling faint, unsteady, or dizzy, particularly when standing quickly (orthostatic hypotension). Results from reduced oxygen delivery to brain and impaired blood pressure regulation.

Pale Skin and Mucous Membranes:

Pallor most noticeable in:

• Conjunctiva: Inner lower eyelids (normally pink, become pale or white)
• Nail beds: Lose normal pink color
• Palms: Pale palm creases (normally should be reddish-pink even in dark-skinned individuals)
• Tongue and gums: Pale instead of normal pink-red

Pallor reflects reduced hemoglobin in blood vessels under skin and mucous membranes.

Rapid or Irregular Heartbeat (Palpitations):

Awareness of heartbeat, feeling heart racing or pounding. Compensatory increase in heart rate to maintain oxygen delivery despite reduced oxygen-carrying capacity.

Cold Hands and Feet:

Extremities feel cold, increased sensitivity to cold temperatures. Blood is preferentially shunted to vital organs (brain, heart, kidneys), reducing peripheral blood flow.

Headaches:

Frequent or persistent headaches resulting from reduced oxygen delivery to brain.

Chest Pain:

Particularly in people with pre-existing heart disease. Anemia reduces oxygen delivery to heart muscle, potentially causing angina (chest pain from inadequate cardiac oxygen supply).

Reduced Exercise Tolerance:

Inability to perform physical activities at previous capacity. Activities requiring increased oxygen consumption become difficult or impossible.

Specific Symptoms by Anemia Type

Iron Deficiency Anemia:

In addition to general anemia symptoms:

• Pica: Craving and eating non-food items—ice (pagophagia, very common), dirt, starch, clay
• Restless leg syndrome: Uncomfortable sensations in legs with urge to move them, particularly at night
• Brittle nails: Thin, spoon-shaped nails (koilonychia) in severe cases
• Sore or swollen tongue: Glossitis with smooth, red tongue
• Cracks at corners of mouth: Angular cheilitis
• Difficulty swallowing: Esophageal webs in severe chronic iron deficiency (Plummer-Vinson syndrome)
• Hair loss: Thinning hair

Vitamin B12 Deficiency:

Beyond anemia symptoms, B12 deficiency causes neurological manifestations:

• Numbness and tingling: Particularly in hands and feet (peripheral neuropathy)
• Difficulty walking: Unsteady gait, balance problems
• Cognitive changes: Memory problems, confusion, difficulty concentrating, in severe cases dementia-like symptoms
• Mood changes: Depression, irritability
• Vision changes: Rarely, optic neuropathy causing vision loss
• Glossitis: Red, smooth, painful tongue

Importantly, neurological symptoms can occur even with mild anemia or sometimes before anemia develops. Untreated B12 deficiency causes progressive, potentially irreversible neurological damage.

Folate Deficiency:

Similar to B12 deficiency in causing macrocytic anemia but neurological symptoms are less common. May have glossitis and general anemia symptoms.

Hemolytic Anemia:

When red blood cells are destroyed too rapidly:

• Jaundice: Yellowing of skin and eyes from bilirubin (red blood cell breakdown product) accumulation
• Dark urine: Tea or cola-colored from hemoglobin byproducts
• Enlarged spleen: Spleen removes damaged red blood cells, becoming enlarged and sometimes painful

Sickle Cell Anemia:

• Pain crises: Severe episodes of pain in bones, chest, abdomen, joints when sickled cells block blood vessels
• Swelling: In hands and feet (dactylitis) in children
• Frequent infections: Impaired immune function
• Delayed growth: In children
• Vision problems: From retinal blood vessel blockages

Severity and Symptoms

Mild Anemia (Hemoglobin 10-12/13 g/dL):

Often asymptomatic or only fatigue with significant exertion. Many people function normally with mild compensated anemia.

Moderate Anemia (Hemoglobin 8-10 g/dL):

Noticeable fatigue, shortness of breath with moderate exertion, reduced exercise tolerance. Symptoms interfere with daily activities.

Severe Anemia (Hemoglobin <8 g/dL):

Significant fatigue even at rest, shortness of breath with minimal exertion, dizziness, rapid heartbeat. Severely impairs quality of life.

Life-Threatening Anemia (Hemoglobin <6.5 g/dL):

Medical emergency. Severe symptoms, risk of heart failure, confusion, loss of consciousness. Requires urgent hospitalization and often blood transfusion.

---

Causes of Anemia

Anemia results from three mechanisms: decreased red blood cell production, increased red blood cell destruction (hemolysis), or blood loss. Multiple causes often coexist.

Iron Deficiency Anemia

The most common cause of anemia worldwide, affecting over 1 billion people.

Inadequate Dietary Iron:

Common in areas with limited meat consumption (heme iron from meat is better absorbed than non-heme iron from plants), vegetarian/vegan diets without careful iron planning, food insecurity. Particularly problematic in children, adolescents, and women of childbearing age with higher iron needs.

Blood Loss:

Menstrual bleeding: Heavy or prolonged periods (menorrhagia) are the leading cause of iron deficiency in premenopausal women. Normal menstrual loss is 30-40 mL blood monthly; >80 mL is abnormal and often causes iron deficiency.

Gastrointestinal bleeding: Chronic slow bleeding from ulcers, gastritis, esophagitis, colon polyps, colon cancer, inflammatory bowel disease, or regular NSAID use (aspirin, ibuprofen). Often occult (hidden)—stool appears normal but contains blood detectable by testing.

Other bleeding: Frequent blood donation (typically causes iron depletion, not anemia, unless donations are very frequent), bleeding disorders, surgical blood loss.

Malabsorption:

Impaired iron absorption in:

• Celiac disease: Gluten damages small intestine, impairing iron absorption
• H. pylori infection: Gastritis from this bacteria impairs iron absorption
• Gastric surgery: Bypass or gastrectomy reduces iron absorption
• Inflammatory bowel disease: Crohn’s disease particularly affects iron absorption
• Medications: Proton pump inhibitors (acid-reducing medications) may impair iron absorption with long-term use

Increased Iron Needs:

Pregnancy: Iron requirements double during pregnancy to support increased maternal blood volume and fetal development. Many pregnant women become iron deficient without supplementation.

Infancy and childhood: Rapid growth increases iron needs. Breastfed infants after 6 months and toddlers are at risk if diet lacks iron-rich foods.

Adolescence: Growth spurts plus onset of menstruation (girls) increase needs.

Vitamin B12 Deficiency

Pernicious Anemia:

An autoimmune condition where antibodies attack parietal cells in stomach lining or intrinsic factor (protein necessary for B12 absorption). Without intrinsic factor, dietary B12 cannot be absorbed. This is the classic cause of severe B12 deficiency with neurological symptoms. More common in elderly, people with other autoimmune diseases, and those of Northern European descent.

Dietary Deficiency:

B12 exists naturally only in animal products (meat, fish, dairy, eggs). Strict vegetarians/vegans without B12 supplementation inevitably become deficient over years (body B12 stores last 2-5 years). Less common in developed countries except among vegans.

Malabsorption:

• Gastric surgery: Removal of stomach portion producing intrinsic factor (gastrectomy, gastric bypass)
• Crohn’s disease: When affecting terminal ileum (site of B12 absorption)
• Celiac disease: May impair B12 absorption
• Pancreatic insufficiency: Inadequate pancreatic enzymes impair B12 release from food
• Medications: Metformin (diabetes medication) impairs B12 absorption; long-term PPI use may contribute

Tapeworm Infection:

Diphyllobothrium latum (fish tapeworm) competes for B12, causing deficiency. Rare in developed countries.

Folate Deficiency

Inadequate Dietary Intake:

Folate is in leafy green vegetables, legumes, fortified grains. Deficiency occurs with poor diet lacking vegetables, chronic alcoholism (alcohol impairs folate absorption and increases urinary folate loss), or eating disorders.

Increased Folate Needs:

Pregnancy: Folate needs increase 50% to support fetal neural tube development. Inadequate folate causes neural tube defects (spina bifida, anencephaly). All women capable of pregnancy should take 400-800 mcg folic acid daily.

Chronic hemolytic anemia: Rapid red blood cell turnover from conditions like sickle cell disease increases folate consumption.

Malabsorption:

Celiac disease, inflammatory bowel disease, certain medications (methotrexate, sulfasalazine, some anticonvulsants).

Anemia of Chronic Disease (Anemia of Inflammation)

The second most common anemia type (after iron deficiency), occurring in people with chronic inflammatory conditions, infections, or cancer.

Mechanisms:

Chronic inflammation produces cytokines (inflammatory signaling molecules) that:

• Reduce red blood cell lifespan
• Impair bone marrow response to erythropoietin
• Trap iron in storage form, making it unavailable for red blood cell production (“functional iron deficiency”)
• Decrease erythropoietin production

Common Causes:

• Chronic kidney disease: Kidneys produce erythropoietin; CKD reduces EPO production (primary mechanism), plus uremia shortens red blood cell lifespan. Anemia develops when eGFR <45-60 and worsens as kidney function declines.
• Cancer: Solid tumors and blood cancers cause anemia through inflammation, bone marrow infiltration, chemotherapy effects, bleeding, or nutritional deficiencies.
• Chronic infections: HIV, hepatitis C, tuberculosis, endocarditis
• Autoimmune diseases: Rheumatoid arthritis, lupus, inflammatory bowel disease
• Chronic heart failure: Multiple mechanisms including inflammation, kidney dysfunction, hemodilution

Bone Marrow Disorders

Aplastic Anemia:

Bone marrow failure reducing production of all blood cell types (red cells, white cells, platelets). Causes include autoimmune attack on marrow, certain medications, toxins (benzene), radiation, viruses, or idiopathic (unknown cause). Severe aplastic anemia is life-threatening.

Myelodysplastic Syndromes (MDS):

Bone marrow produces abnormal, dysfunctional blood cells. Common in elderly. Can progress to acute leukemia.

Leukemia and Lymphoma:

Blood cancers infiltrating bone marrow, crowding out normal blood cell production.

Bone Marrow Infiltration:

Metastatic cancer to bone marrow, multiple myeloma, or other infiltrative processes.

Hemolytic Anemias (Increased Red Blood Cell Destruction)

Inherited Hemolytic Anemias:

Sickle cell disease: Genetic disorder (common in people of African, Mediterranean, Middle Eastern descent) causing abnormal hemoglobin forming “sickle” shapes that block blood vessels and are destroyed prematurely.

Thalassemia: Genetic disorders (common in Mediterranean, Asian, African descent) causing defective hemoglobin production, leading to fragile red blood cells.

G6PD deficiency: Enzyme deficiency causing red blood cell breakdown when exposed to certain triggers (infections, fava beans, certain medications).

Hereditary spherocytosis: Red blood cells are sphere-shaped rather than disc-shaped, destroyed prematurely by spleen.

Acquired Hemolytic Anemias:

Autoimmune hemolytic anemia: Antibodies attack own red blood cells. Can be idiopathic or associated with lupus, lymphoma, certain medications.

Mechanical hemolysis: Artificial heart valves, severe heart valve disease physically destroying red blood cells.

Infections: Malaria destroys red blood cells. Severe bacterial infections sometimes cause hemolysis.

Medications: Certain drugs trigger hemolytic anemia in susceptible individuals.

Other Causes

Hypothyroidism: Mild anemia common, multiple mechanisms.

Chronic liver disease: Reduces red blood cell production, causes bleeding risk, and nutritional deficiencies.

Lead poisoning: Impairs hemoglobin synthesis.

Alcohol abuse: Multiple mechanisms—nutritional deficiencies (folate, B12, iron), direct bone marrow toxicity, liver disease.

---

Diagnosis and Testing for Anemia

Anemia diagnosis requires blood testing. Symptoms alone are nonspecific and insufficient for diagnosis or determining cause.

Complete Blood Count (CBC)

The initial and most important test, measuring multiple blood components:

Hemoglobin:

Confirms anemia if below normal range (<13 g/dL men, <12 g/dL non-pregnant women, <11 g/dL pregnant women). Quantifies anemia severity.

Hematocrit:

Percentage of blood volume occupied by red blood cells. Parallels hemoglobin—low in anemia. Normal: 38-50% (men), 34-46% (women).

Red Blood Cell (RBC) Count:

Number of red blood cells per volume of blood. Low in most anemias. Normal: 4.5-5.5 million/μL (men), 4.0-5.0 million/μL (women).

Red Blood Cell Indices:

These measurements characterize red blood cell size and hemoglobin content, providing crucial clues to anemia cause:

Mean Corpuscular Volume (MCV):

Average red blood cell size. Normal: 80-100 fL.

• Microcytic (MCV <80 fL): Small red blood cells—iron deficiency, thalassemia, chronic disease anemia, lead poisoning
• Normocytic (MCV 80-100 fL): Normal-sized red blood cells—acute blood loss, hemolytic anemia, chronic disease anemia, kidney disease, bone marrow disorders
• Macrocytic (MCV >100 fL): Large red blood cells—B12 deficiency, folate deficiency, liver disease, hypothyroidism, certain medications, alcohol abuse

Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC):

Average hemoglobin content per red blood cell and hemoglobin concentration. Low in iron deficiency (hypochromic anemia).

Red Cell Distribution Width (RDW):

Variation in red blood cell size. Elevated RDW indicates mixed red blood cell sizes (anisocytosis), suggesting:

• Combined nutritional deficiencies (iron + B12/folate)
• Recent transfusion
• Early response to treatment
• Some chronic anemias

Normal RDW with anemia suggests thalassemia trait or chronic disease anemia.

Reticulocyte Count:

Young, immature red blood cells recently released from bone marrow. Reticulocyte count indicates bone marrow’s red blood cell production activity:

Elevated reticulocyte count (>2%): Bone marrow responding appropriately—suggests blood loss or hemolysis (increased destruction requiring increased production).

Low or normal reticulocyte count (<1-2%): Inadequate bone marrow response—suggests nutritional deficiencies, bone marrow disorders, chronic disease anemia, or chronic kidney disease where production is impaired.

Reticulocyte count helps distinguish production problems from destruction/loss problems.

Iron Studies

Essential for evaluating iron status and diagnosing iron deficiency anemia:

Serum Ferritin:

Reflects body iron stores. The single best test for iron deficiency.

• Normal: 30-300 ng/mL (varies by lab)
• <30 ng/mL: Indicates iron deficiency (some labs use <20 or <15 ng/mL)
• <100 ng/mL in context of chronic disease/inflammation: May indicate functional iron deficiency

Important note: Ferritin is an acute-phase reactant—it increases with inflammation, infection, or liver disease, potentially masking iron deficiency. Someone with both iron deficiency and inflammation might have “normal” ferritin despite depleted iron stores.

Serum Iron:

Amount of iron in blood. Low in iron deficiency, but varies throughout day and with recent meals, making it less reliable than ferritin.

Total Iron-Binding Capacity (TIBC):

Measures transferrin (iron transport protein) capacity to bind iron. Normal: 250-450 mcg/dL.

• High TIBC: Iron deficiency (body produces more transferrin trying to capture any available iron)
• Low TIBC: Chronic disease anemia, liver disease

Transferrin Saturation:

Percentage of transferrin binding sites occupied by iron. Calculated: (Serum Iron / TIBC) × 100.

• Normal: 20-50%
• <20%: Iron deficiency
• <16%: Definite iron deficiency

Iron Study Patterns:

Iron Deficiency Anemia:

• Ferritin: Low (<30 ng/mL)
• Serum iron: Low
• TIBC: High (>450 mcg/dL)
• Transferrin saturation: Low (<20%)

Anemia of Chronic Disease:

• Ferritin: Normal or high (inflammation elevates ferritin)
• Serum iron: Low
• TIBC: Low or normal
• Transferrin saturation: Low-normal

Vitamin Testing

Vitamin B12 (Cobalamin):

Normal: 200-900 pg/mL (varies by lab). Some experts recommend >300-400 pg/mL for optimal health.

• <200 pg/mL: B12 deficiency
• 200-300 pg/mL: Borderline—consider functional B12 deficiency

If B12 is low or borderline, additional tests help:

Methylmalonic Acid (MMA):

Elevated (>0.4 μmol/L) in B12 deficiency. More sensitive than B12 level alone for detecting functional deficiency. Normal MMA with low-normal B12 argues against true deficiency.

Homocysteine:

Elevated in both B12 and folate deficiency. Less specific than MMA.

Intrinsic Factor Antibodies:

Positive in pernicious anemia. Highly specific (if positive, confirms pernicious anemia) but not sensitive (negative doesn’t exclude pernicious anemia).

Folate (Folic Acid):

Serum folate: Normal >3-4 ng/mL. Low serum folate indicates folate deficiency.

Red blood cell folate: More accurately reflects tissue stores than serum folate.

Additional Testing Based on Clinical Suspicion

Peripheral Blood Smear:

Microscopic examination of blood cells provides morphologic clues:

• Microcytic, hypochromic cells: Iron deficiency
• Macrocytic cells: B12/folate deficiency
• Schistocytes (fragmented cells): Hemolytic anemia
• Sickled cells: Sickle cell disease
• Target cells: Thalassemia, liver disease

Stool Occult Blood Test:

If gastrointestinal bleeding suspected (particularly in men or postmenopausal women with iron deficiency), tests for hidden blood in stool. Positive result warrants colonoscopy/endoscopy to identify bleeding source.

Hemoglobin Electrophoresis:

Identifies abnormal hemoglobin variants (sickle cell disease, thalassemia). Ordered when these conditions are suspected based on ethnicity, family history, or blood smear findings.

Bone Marrow Biopsy:

Rarely needed but essential when bone marrow disorder suspected (aplastic anemia, myelodysplastic syndrome, leukemia, unexplained anemia). Involves removing small bone marrow sample from hipbone for microscopic examination.

Additional Labs:

• Kidney function (creatinine, eGFR): Assess for CKD
• Thyroid function (TSH): Hypothyroidism can cause anemia
• Liver function: Liver disease contributes to anemia
• Inflammatory markers (CRP, ESR): Elevated in chronic disease anemia
• Lactate dehydrogenase (LDH), haptoglobin, indirect bilirubin: Elevated in hemolytic anemia

---

Treatment of Anemia

Treatment depends entirely on anemia type and underlying cause. Simply supplementing iron or B12 without identifying cause can mask serious conditions like colon cancer bleeding or pernicious anemia.

Iron Deficiency Anemia Treatment

Identify and Address Underlying Cause:

Crucial step before or concurrent with iron supplementation:

• Heavy menstrual bleeding: Gynecologic evaluation, contraceptive management, or surgical options (endometrial ablation, hysterectomy for severe cases)
• Gastrointestinal bleeding: Endoscopy and colonoscopy to identify ulcers, polyps, cancer. Treat H. pylori, discontinue NSAIDs if possible, manage inflammatory bowel disease.
• Dietary insufficiency: Nutritional counseling, dietary modifications
• Malabsorption: Treat celiac disease (gluten-free diet), consider alternative iron formulations

Iron Supplementation:

Oral Iron:

First-line treatment. Multiple formulations:

• Ferrous sulfate (20% elemental iron): Most common, typically 325 mg tablets (65 mg elemental iron) taken 1-3 times daily
• Ferrous gluconate (12% elemental iron): Better tolerated by some
• Ferrous fumarate (33% elemental iron): More elemental iron per tablet
• Polysaccharide iron complex: Well-tolerated alternative
• Carbonyl iron: Another alternative

Dosing: Typical dose is 100-200 mg elemental iron daily, though lower doses (40-60 mg) may be as effective with fewer side effects. Take on empty stomach for best absorption (though this increases side effects). Vitamin C (orange juice) enhances absorption. Calcium, antacids, tea, coffee impair absorption—separate by 2+ hours.

Side effects: Nausea, constipation, diarrhea, black stools, abdominal cramping in 30-50% of people. Start with lower dose, take with small amount of food if necessary, try different formulations, consider every-other-day dosing (absorption may be better than daily).

Duration: Continue 3-6 months after hemoglobin normalizes to replenish iron stores.

Response monitoring: Recheck hemoglobin in 4-6 weeks. Reticulocyte count rises within 1-2 weeks. Hemoglobin increases approximately 1 g/dL every 2-3 weeks with adequate treatment. If no improvement, consider non-adherence, continued blood loss, malabsorption, or incorrect diagnosis.

Intravenous (IV) Iron:

Indicated when:

• Oral iron not tolerated despite trying multiple formulations
• Malabsorption (celiac disease, inflammatory bowel disease, gastric bypass)
• Need for rapid iron repletion (pregnancy, planned surgery)
• Chronic kidney disease patients on dialysis
• Ongoing blood loss exceeding oral replacement capacity

Multiple IV iron formulations (iron sucrose, ferric carboxymaltose, iron dextran) administered as infusions. Effective and fast—hemoglobin rises quickly. Risks include allergic reactions (rare but potentially severe with older formulations like high-molecular-weight iron dextran).

Vitamin B12 Deficiency Treatment

B12 Replacement:

Intramuscular Injections:

Traditional treatment, especially for pernicious anemia (no intrinsic factor for absorption). Typical regimen:

• Loading phase: 1000 mcg IM daily for 1-2 weeks (replenishes stores)
• Maintenance: 1000 mcg IM monthly lifelong

Injections bypass absorption problems, ensuring adequate B12 delivery.

High-Dose Oral B12:

Surprisingly, very high oral doses (1000-2000 mcg daily) achieve adequate absorption even without intrinsic factor through passive diffusion (small percentage absorbed without intrinsic factor). Effective for many people with pernicious anemia and preferred by some over injections. Requires daily compliance.

Sublingual B12:

Absorbed under tongue, avoiding gastric factors. 1000-2000 mcg daily. Effective alternative to injections for many people.

Nasal Spray:

500 mcg once weekly. Less commonly used.

Dietary B12:

For dietary deficiency in vegetarians/vegans—B12-fortified foods (plant milks, cereals, nutritional yeast) or oral supplements (typically 25-100 mcg daily for prevention, higher for treatment).

Response: Reticulocyte count peaks 5-7 days after starting treatment. Hemoglobin normalizes over 1-2 months. Neurological symptoms improve slowly over months; some damage may be permanent if deficiency was prolonged.

Treat Underlying Cause:

If pernicious anemia, lifelong B12 replacement required. If dietary insufficiency, supplement or modify diet. If medication-induced (metformin, PPIs), continue B12 supplementation while on medications.

Folate Deficiency Treatment

Folic Acid Supplementation:

Oral folic acid 1-5 mg daily for 1-4 months corrects deficiency. Much higher doses than dietary intake (400 mcg) due to deficiency severity.

Dietary Folate:

Increase leafy greens, legumes, fortified grains once deficiency corrected.

Important: Always check B12 before treating with folate. Giving folate to someone with undiagnosed B12 deficiency can mask anemia (hemoglobin improves) while neurological damage progresses. Once B12 deficiency is excluded, folic acid is safe.

Prevent Deficiency:

All women capable of pregnancy should take 400-800 mcg folic acid daily to prevent neural tube defects if pregnancy occurs.

Anemia of Chronic Disease Treatment

Treat Underlying Condition:

Primary approach. Successful treatment of inflammatory condition, infection, or cancer often improves or resolves anemia.

Erythropoiesis-Stimulating Agents (ESAs):

Synthetic erythropoietin (epoetin alfa, darbepoetin alfa) stimulates red blood cell production. Used primarily in:

• Chronic kidney disease: When anemia causes symptoms, particularly dialysis patients. Target hemoglobin 10-11.5 g/dL (higher targets increase cardiovascular risk).
• Cancer chemotherapy-related anemia: When severe and symptomatic. Use is controversial—ESAs may promote tumor growth in some cancers.

ESAs are expensive, require injections, and carry risks (hypertension, blood clots, cardiovascular events). Reserved for specific indications.

Iron Supplementation:

If functional iron deficiency (ferritin <100 ng/mL with inflammation, transferrin saturation <20%), IV iron may help, particularly in CKD patients.

Hemolytic Anemia Treatment

Depends on specific cause:

Autoimmune Hemolytic Anemia:

Corticosteroids (prednisone) suppress immune system attacking red blood cells. Immunosuppressants (azathioprine, cyclophosphamide) for refractory cases. Sometimes splenectomy (spleen removal) if medications fail.

Inherited Hemolytic Anemias:

Sickle cell disease: Hydroxyurea (increases fetal hemoglobin, reducing sickling), chronic transfusions for severe cases, bone marrow transplant (potentially curative but high-risk). Pain management for crises. New therapies (voxelotor, crizanlizumab, gene therapy) emerging.

Thalassemia: Regular blood transfusions for severe forms (thalassemia major), iron chelation to prevent iron overload from transfusions, bone marrow transplant potentially curative.

G6PD deficiency: Avoid triggers (certain medications, fava beans, infections). Episodes usually resolve spontaneously once trigger removed.

Aplastic Anemia and Bone Marrow Disorders

Aplastic Anemia:

Severe cases require immunosuppressive therapy (antithymocyte globulin, cyclosporine) or hematopoietic stem cell transplant (curative but requires matched donor). Supportive care includes transfusions, antibiotics for infections.

Myelodysplastic Syndromes:

Treatment varies from observation (low-risk MDS) to chemotherapy, ESAs, transfusions, or stem cell transplant (high-risk MDS).

Blood Transfusion

Indicated for:

• Severe symptomatic anemia (typically hemoglobin <7-8 g/dL)
• Acute blood loss causing hemodynamic instability
• Symptomatic anemia when underlying cause cannot be rapidly corrected

Transfusion provides immediate hemoglobin increase (each unit raises hemoglobin ~1 g/dL) but is temporary—underlying cause must still be addressed. Risks include allergic reactions, transfusion reactions, iron overload (with chronic transfusions), infections (very rare with modern blood banking).

---

Early Detection and Prevention of Anemia

While not all anemias are preventable (genetic conditions, autoimmune diseases, cancers), many common anemias can be prevented or detected early through awareness, screening, and addressing risk factors.

Who Is at Risk for Anemia?

Women of Childbearing Age:

Menstrual blood loss causes chronic iron loss. Women with heavy periods (soaking through pads/tampons hourly, periods >7 days, large clots) are at particularly high risk. Additionally, pregnancy and childbirth increase iron demands and risks.

Pregnant Women:

Iron requirements double during pregnancy. Without supplementation, iron deficiency develops in 30-50% of pregnant women, increasing risks for mother (fatigue, increased infections, postpartum hemorrhage complications) and baby (low birth weight, preterm birth, developmental issues).

Infants and Young Children:

Rapid growth increases iron needs. At-risk groups:

• Preterm infants (born with lower iron stores)
• Breastfed infants after 6 months without iron-rich complementary foods
• Toddlers consuming excessive cow’s milk (>24 oz daily displaces iron-rich foods; cow’s milk is iron-poor)
• Picky eaters with limited meat/iron-fortified food intake

Adolescents:

Growth spurts plus onset of menstruation (girls) increase iron needs. Many adolescents have inadequate dietary iron intake.

Frequent Blood Donors:

Donating whole blood every 8 weeks (maximum frequency) causes iron depletion. About 25-35% of regular donors develop iron deficiency. Iron supplementation recommended for frequent donors.

People with Chronic Diseases:

• Chronic kidney disease: Anemia develops as kidney function declines (eGFR <45-60)
• Heart failure: 30-50% have anemia
• Cancer: Both cancer and chemotherapy cause anemia
• Autoimmune diseases: Inflammatory bowel disease, rheumatoid arthritis, lupus
• HIV infection

Older Adults:

Anemia prevalence increases with age—10% at age 65, rising to 20-30% by age 85. Causes include chronic diseases, nutritional deficiencies (often from reduced intake or absorption), medications, and undiagnosed bleeding (particularly GI bleeding from polyps, cancer, or NSAID use).

Vegetarians and Vegans:

At risk for iron deficiency (non-heme plant iron is less bioavailable than heme animal iron) and B12 deficiency (B12 exists only in animal products). Careful dietary planning or supplementation prevents deficiency.

People with Malabsorption:

• Celiac disease (affects 1% of population, often undiagnosed)
• Inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
• Gastric surgery (bypass, gastrectomy)
• Chronic diarrhea from any cause

People Taking Certain Medications:

• NSAIDs (aspirin, ibuprofen, naproxen): Increase GI bleeding risk
• Proton pump inhibitors (PPIs): May impair iron and B12 absorption
• Metformin: Impairs B12 absorption in 10-30% of long-term users
• Anticoagulants: Increase bleeding risk

People with Gastrointestinal Symptoms:

Chronic diarrhea, abdominal pain, unexplained weight loss may indicate conditions causing anemia (inflammatory bowel disease, celiac disease, GI bleeding).

Early Warning Signs: When to Suspect Anemia

Progressive Fatigue:

Worsening tiredness over weeks to months, reduced exercise tolerance, increased need for rest. When fatigue accompanies other anemia symptoms or occurs in high-risk individuals, anemia should be suspected.

Shortness of Breath with Exertion:

New or worsening breathlessness during activities previously tolerated easily. Particularly concerning if accompanied by palpitations or chest discomfort.

Pallor:

Friends or family noticing you look pale. Check lower eyelid conjunctiva (inner eyelid), nail beds, palm creases—should be pink-red, not pale or white.

Unexplained Dizziness or Lightheadedness:

Particularly when standing quickly, during exertion, or if frequent.

Changes in Menstrual Pattern:

Periods becoming heavier, longer, or more frequent. Soaking through pads/tampons hourly, passing large clots (>quarter-size), or bleeding lasting >7 days warrants evaluation.

Unusual Food Cravings:

Specifically craving ice, dirt, starch, or clay (pica) is highly specific for iron deficiency.

Neurological Symptoms:

Numbness, tingling in hands/feet, difficulty walking, memory problems, or mood changes—particularly in vegetarians/vegans, elderly, or people with malabsorption—may indicate B12 deficiency.

Jaundice or Dark Urine:

Yellow skin/eyes or tea-colored urine suggests hemolytic anemia (red blood cell destruction).

These Symptoms Don’t Diagnose Anemia:

All symptoms are nonspecific—many conditions cause fatigue, shortness of breath, dizziness. However, when multiple symptoms occur together, particularly in high-risk individuals, blood testing is warranted.

The Importance of Laboratory Testing for Early Detection

Why Symptoms Alone Are Insufficient:

Anemia symptoms (particularly fatigue, weakness, shortness of breath) overlap with countless conditions—hypothyroidism, depression, heart disease, lung disease, sleep disorders, deconditioning, stress. Additionally, mild anemia often causes no symptoms, and gradual-onset anemia allows compensation, masking severity. Blood testing is the only reliable way to diagnose anemia, determine severity, and identify cause.

When Blood Testing Is Recommended:

Symptoms Suggesting Anemia:

Anyone experiencing persistent fatigue, weakness, shortness of breath, dizziness, pallor, or other concerning symptoms should have a complete blood count (CBC).

Routine Screening in High-Risk Groups:

Pregnant Women: CBC at first prenatal visit and repeated in third trimester (24-28 weeks). Iron supplementation typically recommended throughout pregnancy.

Infants and Young Children: Screen at 12 months for iron deficiency. Earlier screening (6-9 months) for preterm infants or other risk factors.

Women with Heavy Menstrual Bleeding: Annual CBC or when bleeding pattern changes.

Frequent Blood Donors: Screen ferritin every 1-2 donations or annually. Many blood centers now check hemoglobin before each donation.

Chronic Disease Patients: Regular monitoring—CKD patients every 3-6 months, cancer patients during chemotherapy, heart failure patients annually.

Elderly Individuals: Consider CBC every 1-2 years after age 65, or annually if risk factors present.

Comprehensive Testing When Anemia Confirmed:

CBC confirms anemia and provides initial clues (MCV categorizes as microcytic, normocytic, or macrocytic), but additional testing identifies specific cause:

• Microcytic anemia: Iron studies (ferritin, serum iron, TIBC, transferrin saturation), consider hemoglobin electrophoresis if thalassemia suspected
• Macrocytic anemia: B12 and folate levels, thyroid function, consider liver function tests
• Normocytic anemia: Reticulocyte count, kidney function, assess for chronic diseases, consider hemolysis workup if suspected

For Men and Postmenopausal Women with Iron Deficiency:

GI bleeding must be excluded—stool occult blood testing, often colonoscopy and upper endoscopy to identify bleeding sources (ulcers, polyps, cancer).

The Value of Early Detection:

Symptom Relief: Treating anemia dramatically improves energy, exercise tolerance, cognitive function, and quality of life. Many people adapt to gradual anemia, not realizing how impaired they’ve become until treatment restores normal hemoglobin.

Identifying Serious Underlying Conditions: Anemia may be the first sign of colon cancer, celiac disease, chronic kidney disease, or other conditions requiring treatment. Early detection enables earlier intervention for these conditions.

Preventing Complications: Severe untreated anemia can cause heart failure (heart compensating for low oxygen-carrying capacity enlarges and weakens). Chronic anemia impairs cognitive function, immune function, and in pregnant women, causes pregnancy complications.

Preventing Irreversible Damage: B12 deficiency causes progressive neurological damage that becomes permanent if untreated too long. Early detection and treatment prevents irreversible complications.

Cost-Effectiveness:

CBC is inexpensive ($10-30), simple (single blood draw), and provides enormous information. The cost of missing anemia—years of reduced quality of life, missed underlying diagnoses (like colon cancer), complications (heart failure, cognitive decline)—far exceeds testing costs.

What Can Be Prevented

Primary Prevention (Preventing Anemia Development):

Adequate Dietary Iron:

Ensure sufficient iron intake:

• Heme iron (better absorbed): Red meat, poultry, fish
• Non-heme iron: Legumes, fortified cereals, leafy greens, dried fruit. Enhance absorption by consuming with vitamin C (citrus, peppers, tomatoes); avoid consuming with calcium, tea, coffee (impair absorption).

Recommended dietary allowances:

• Adult men: 8 mg daily
• Women 19-50: 18 mg daily
• Pregnant women: 27 mg daily
• Postmenopausal women: 8 mg daily

Iron Supplementation in High-Risk Groups:

• All pregnant women: 27-30 mg elemental iron daily (usually in prenatal vitamins)
• Infants: Iron-fortified formula or iron supplements starting 4-6 months for breastfed infants
• Frequent blood donors: Consider routine iron supplementation

B12 Sources:

• Animal products (meat, fish, eggs, dairy) for omnivores
• Vegetarians/vegans: B12-fortified foods or supplements (2.4 mcg daily minimum, higher for vegans)

Folate Sources:

Leafy greens, legumes, fortified grains. All women capable of pregnancy should take 400-800 mcg folic acid daily to prevent neural tube defects.

Minimize Blood Loss:

• Treat heavy menstrual bleeding (hormonal management, gynecologic procedures)
• Manage NSAIDs carefully—use lowest effective dose, consider alternatives, take with food, possibly add acid-reducing medication if chronic use necessary
• Treat H. pylori if present (reduces ulcer risk and improves iron absorption)

Secondary Prevention (Early Detection and Intervention):

Since complete prevention is impossible, early detection enables timely treatment:

Screening High-Risk Groups:

Routine CBC in pregnant women, infants, people with chronic diseases, frequent donors enables detection before severe anemia develops.

Prompt Evaluation of Symptoms:

Don’t dismiss persistent fatigue, pallor, or shortness of breath as “normal” or “just stress”—seek medical evaluation and blood testing.

Investigate Underlying Causes:

Men and postmenopausal women with iron deficiency should have GI evaluation to detect bleeding sources. Treating colon polyps before they become cancerous, managing ulcers, or addressing inflammatory bowel disease prevents ongoing blood loss and anemia recurrence.

Tertiary Prevention (Preventing Complications):

Once anemia is diagnosed:

Appropriate Treatment: Iron supplementation, vitamin replacement, or addressing underlying diseases corrects anemia, preventing progression to severe anemia and complications.

Monitoring During Treatment: Regular CBC monitoring (every 4-6 weeks initially) ensures treatment effectiveness and hemoglobin normalization.

Long-Term Management: For chronic conditions causing anemia (CKD, inflammatory diseases, malabsorption), ongoing monitoring and treatment adjustments prevent anemia recurrence.

The overarching message: While genetic and autoimmune anemias aren’t preventable, most common anemias—iron deficiency, B12 deficiency, folate deficiency—can be prevented through adequate nutrition, appropriate supplementation in high-risk groups, and managing underlying conditions. Early detection through blood testing in symptomatic or high-risk individuals enables effective treatment before complications develop.

---

Living With Anemia

For people with chronic anemia (from chronic diseases, genetic conditions, or recurrent deficiencies), understanding management, realistic expectations, and self-care is essential.

Medication and Supplement Adherence

Iron Supplements:

Must be taken consistently for 3-6 months to replenish stores. If side effects occur, don’t stop—try different formulations, lower doses, every-other-day dosing, or taking with small amount of food.

B12 Supplements or Injections:

Lifelong treatment for pernicious anemia or irreversible malabsorption. Monthly injections or daily oral high-dose supplements. Consistency is crucial—skipping treatments allows deficiency to recur.

Managing Side Effects:

Iron constipation: Increase fiber, fluids, exercise; consider stool softeners. Iron nausea: Take with food, try different formulation, split dose. Black stools are expected and harmless.

Dietary Management

Iron-Rich Diet:

Include heme iron sources (meat, fish, poultry) if not vegetarian. Plant-based sources with vitamin C (spinach with lemon, beans with peppers). Avoid tea/coffee with meals.

B12 Sources:

Animal products or fortified foods. Vegetarians/vegans must supplement.

Folate Sources:

Leafy greens, legumes, fortified grains.

Monitoring and Follow-Up

Regular Blood Tests:

Initially every 4-6 weeks during treatment. Once stable, annually or per healthcare provider recommendations. For chronic conditions (CKD, cancer), more frequent monitoring.

Symptom Monitoring:

Pay attention to fatigue levels, exercise tolerance, shortness of breath. Worsening symptoms warrant medical evaluation and blood testing.

Special Considerations

Pregnancy:

Women with history of anemia need close monitoring during pregnancy. Prenatal vitamins with iron and early intervention if anemia develops.

Surgery:

Anemia increases surgical risks. If elective surgery is planned and anemia is present, postpone surgery and treat anemia first if possible.

Exercise:

Moderate exercise is generally safe and beneficial even with mild-moderate anemia. Severe anemia (hemoglobin <8 g/dL) may require activity restriction until improved.

When to Seek Medical Attention

Worsening Symptoms:

Increasing fatigue, new shortness of breath at rest, severe dizziness, chest pain, rapid heartbeat warrant urgent evaluation.

New Symptoms:

Yellowing skin/eyes, very dark/black urine (except expected black stools from iron), severe weakness, confusion require immediate medical attention.

Lack of Improvement:

If symptoms don’t improve after 4-6 weeks of appropriate treatment, contact healthcare provider—may indicate continued blood loss, malabsorption, incorrect diagnosis, or need for different treatment approach.

---

Anemia is one of the world’s most common health conditions, affecting billions worldwide. While causes vary from simple iron deficiency to complex genetic disorders, most anemias are diagnosable through blood testing and treatable with appropriate interventions. Early detection through screening high-risk groups and prompt evaluation of symptoms enables effective treatment, preventing complications and dramatically improving quality of life.